Research suggests that goji berry (Lycium barbarum) has a long history of traditional use for anti-aging and general nourishment, and modern pharmacological work has begun identifying the bioactive compounds—including polysaccharides, zeaxanthin dipalmitate, and betaine—that may underlie these effects. The available evidence consists of a 2018 botanical review summarizing historical and ethnobotanical literature alongside contemporary pharmacological findings, and a 2025 laboratory study examining goji berry as part of a five-plant combination in human fibroblast and skin tissue models, where the combination appeared to reduce markers of cellular aging and support collagen production. Both studies point in a supportive direction, but the evidence base is limited in scope—neither study involves human clinical trials, and the laboratory findings in particular cannot be directly extrapolated to real-world outcomes in people. Studies indicate that while the traditional rationale for goji berry's anti-aging reputation has some pharmacological grounding, rigorous clinical research, such as randomized controlled trials, would be needed before stronger conclusions can be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| The genus Lycium as food and medicine: A botanical, ethnobotanical and histor... | Review | 2018 | Supports | 100 |
| A Multidimensional Study Integrating Traditional Chinese Medicine and Network... | Other | 2025 | Supports | 95 |